Dr. Aaron Royston is a Managing Partner at venBio, bringing over 15 years of expertise in life sciences investing, company formation and operations, strategic and product planning, and clinical research. He has helped to launch and invest in multiple venBio portfolio companies, whose efforts have resulted in six FDA-approved drugs. Dr. Royston received his B.S. in Biological Sciences from Duke University, and his M.D. and MBA degrees from the University of Pennsylvania.